Does Cepheid have stock?

Notice: Cepheid stock has been delisted and is no longer actively trading. Cepheid is now a division of Danaher Corporation (NYSE:DHR).

What is Cphd stock price?

52.95
Key Turning Points

52-Week High	53.91
Last Price	52.95
Fibonacci 61.8%	42.90
Fibonacci 50%	39.50
Fibonacci 38.2%	36.10

Is KD stock a good buy?

The financial health and growth prospects of KD, demonstrate its potential to outperform the market. It currently has a Growth Score of C. Recent price changes and earnings estimate revisions indicate this would not be a good stock for momentum investors with a Momentum Score of D.

What industry is Cepheid in?

molecular diagnostics company
Cepheid operates as a molecular diagnostics company, which develops, manufactures, and markets fully-integrated systems for testing in the clinical market, as well as for application in the company’s legacy industrial, biothreat and partner markets.

When did Danaher buy Cepheid?

Nov 4, 2016
Danaher Completes Acquisition Of Cepheid – Nov 4, 2016.

Does Danaher own Cepheid?

6, 2016 /PRNewswire/ — Danaher Corporation (NYSE:DHR) (“Danaher” or the “Company”) announced today that it has entered into a definitive merger agreement with Cepheid (NASDAQ:CPHD) pursuant to which Danaher will acquire all of the outstanding shares of Cepheid for $53.00 per share in cash, or a total enterprise value …

What does Cphd stand for?

CPHD

Acronym	Definition
CPHD	Combined Pituitary Hormone Deficiency
CPHD	Conference on Public Health and Disasters (Center for Public Health and Disasters; University of California, Los Angeles)
CPHD	Centre for Policy and Human Development (Afghanistan)
CPHD	Chronic Pulmonary Heart Disease

Does kd pay a dividend?

KD does not currently pay a dividend.

Where did Kyndryl holdings come from?

Kyndryl Holdings, Inc. (“Kyndryl”) was recently spun off from International Business Machines Corporation (“IBM”), with IBM distributing 80.1% of its Kyndryl shares to IBM shareholders on November 3, 2021 (the “Distribution”).

What company makes GeneXpert?

US-based leading molecular diagnostics company, Cepheid Inc. (a wholly owned subsidiary of Danaher) unveiled its newest configuration in the GeneXpert® family of systems, the GeneXpert® Edge, in the country today.

What is Cepheid GeneXpert?

Product Information. Our GeneXpert® family of systems have set a new standard in workflow flexibility, 24/7 testing accuracy, and user-friendly design — delivered in an astonishingly beautiful and compact package. The GeneXpert System is available in a two, four, or 16-module configuration.

What company makes Cepheid?

Danaher
Targeted for physician office and other near-patient applications, the connected and portable GeneXpert Omni debuted in late 2019, in ex-U.S. territories. Today, Cepheid operates within the Danaher family of Operating Companies.

Cepheid | GeneXpert System Cepheid’s GeneXpert® family of systems have set a new standard in workflow flexibility, 24/7 testing accuracy, and user-friendly design-delivered in an astonishingly beautiful and compact package. You are using an unsupported browser. Some features of this site may not function properly.

What is the GeneXpert Infinity?

The GeneXpert Infinity provides maximum flexibility in system placement, staffing, and menu availability. Cepheid C360 Cepheid C360 securely collects and aggregates, in dashboard format, real-time information from any GeneXpert System to enhance productivity and performance.

What is the difference between Cepheid C360 and GeneXpert Infinity?

Why choose Cepheid systems&solutions?

Cepheid’s Systems & Solutions Team is here to help you quantify the value of adding a new technology, like the GeneXpert System, to your institution — from the laboratory to the Hospital floor. Making a Positive Impact, Together.